RESUMO
PURPOSE: Complementary and integrative medicine (CIM) use during cancer care has increased in Western medical settings. Little is known about interest in and use of CIM approaches by oncology patients in Chile and South America. PATIENTS AND METHODS: Patients presenting for conventional outpatient or inpatient medical oncology care at the Clinica Alemana in Santiago, Chile, from March to June 2017 were asked to complete a survey about their interest in and use of CIM approaches. Goals included determining the prevalence of CIM use and exploring associations between CIM use and patient characteristics. Statistical analyses included a two-tailed t test for continuous variables, Fischer's exact test for categorical variables, and logistic regression for association between CIM use and other variables. RESULTS: Of 432 patients surveyed, 66.9% were diagnosed with breast cancer, 84.8% were women, the majority of patients (58.1%) were between age 40 and 60 years, and 51.5% (n = 221) reported CIM use. No association was found between CIM use and the sociodemographic variables of sex, age, education, or income. In all, 44.6% of patients with breast cancer reported CIM use compared with 64.8% of patients with other cancer types (P > .001). Most commonly reported types of CIM used included herbals (49.1%), vitamins and minerals (40.8%), and prayer or meditation (40.4%). Most frequent reasons for CIM use were to "do everything possible" (72%) and to "improve my immune function" (67.8%). Most patients (43.4%) reported starting CIM use at the time of cancer diagnosis, with only 55.4% sharing information regarding CIM use with their medical team. CONCLUSION: The majority of patients surveyed reported engaging in CIM use, with just over half the users communicating with their oncology team about their CIM use. Increased awareness of regional differences in CIM use may help increase communication regarding this subject and contribute to improved outcomes.
Assuntos
Terapias Complementares , Atenção à Saúde , Medicina Integrativa , Neoplasias/epidemiologia , Aceitação pelo Paciente de Cuidados de Saúde , Adulto , Idoso , Chile , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , PrevalênciaRESUMO
BACKGROUND: The success of orthotopic liver transplantation (OLT) has resulted in its widespread use for different liver diseases. AIM: To report our 8 years experience with adult OLT at Clinica Alemana de Santiago. PATIENTS AND METHODS: In all transplantations done at the center, we recorded patient's overall data and survival, postoperative medical and surgical complications and causes of death. RESULTS: Between November 1993 and September 2001, 51 consecutive OLT were performed in 44 patients (22 females, median age 45 years old). Thirty eight patients presented with chronic and 6 with acute or sub-acute liver failure. Cryptogenic cirrhosis and hepatitis C infection were the most common causes for OLT. Postoperative bleeding and extrahepatic biliary complications were seen in 17.6 and 21.5% of cases respectively. Acute rejection, bacterial infections, CMV infection or disease and post OLT hemodialysis were the most common medical complications (51, 31, 19.6 and 19.6% of cases respectively). The overall 1 and 5 years survival rates were 80% and 73% respectively. Considering exclusively the last 22 OLT performed since January 1999, the 1 year survival rate has improved to 91%. CONCLUSIONS: Liver transplantation in Chile provides a good long term survival with acceptable morbidity, due to a multidisciplinary approach management. The survival rates have improved over the last few years probably due to better surgical techniques, ICU care and immunosuppression. These overall results are comparable with those from other Centers in developed countries.
Assuntos
Hepatopatias/cirurgia , Transplante de Fígado/mortalidade , Adolescente , Adulto , Idoso , Feminino , Rejeição de Enxerto , Humanos , Falência Hepática/cirurgia , Transplante de Fígado/efeitos adversos , Transplante de Fígado/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/mortalidade , Reoperação , Taxa de SobrevidaRESUMO
Sesenta y nueve pacientes ASA I y II sometidos a cirugía de hemiabdomen superior, fueron asignados al azar a uno de 5 esquemas analgésicos, iniciados en la inducción anestésica y mantenidos durante 24 horas: I: ketoprofeno 100 mg IV c/8 horas. II: fentanyl 4 µg/kg en bolo + infusión de 1 µg/kg-1/h-1. III: morfina 4 mg vía peridural lumbar. IV: metadona 0,1 mg/kg IM c/8 h. V: morfina 0,1 mg/kg en bolo + infusión de 10 µg/kg-1/h-1. Fueron evaluados por un observador entrenado que desconocía el esquema utilizado, a través de: 1) Escala visual análoga (EVA); 2) Escala de valoración verbal (EVV) en reposo; 3) Fascie del paciente en reposo y en movimiento; 4) EVV retrospectiva; 5) Número de analgésicos adicionales; 6) Aceptabilidad al método. Las evaluaciones se hicieron a las 2, 4, 6, 12, 24, 36, 48 horas de iniciado el esquema, consignándose además: FR, PA, FC, presencia de náuseas, vómitos, retención urinaria, prurito y grado de sedación. Se controló gases en sangre arterial a las 2, 12 y 24 horas. Se hizo ANOVA + t-Test o Chi cuadrado, según correspondía. Todos los grupos fueron comparables. Hubo mejor analgesia en los grupos II, III y IV, habiendo diferencia significativa para el grupo II. Todos lod grupos requirieron analgésicos adicionales, siendo el promedio menor en el grupo II. No hubo diferencia intergrupo en cuanto a náuseas, vómitos y retención urinaria. La aceptabilidad al método fue buena. La PaO2 fue similar en todos los grupos. No hubo retención de CO2 en ningún grupo, siendo la PaCO2 significativamente menor en el grupo I. Hubo alivio del dolor con los 5 esquemas utilizados, siendo mejor el esquema II. Tuvimos buena aceptación al método y no hubo complicaciones inherentes a él